TABLE 3.
Effect of patient characteristics on hospital costa by univariate analysis
| Variable (no. of patients no/no. of patients yes) | Median ± SD (range) total hospital costa ($) |
P valueb | |
|---|---|---|---|
| No | Yes | ||
| Resistant pathogen (469/193) | 106,293 ± 125,018 (152-924,661) | 144,414 ± 178,528 (5,191-1,056,054) | <0.0001 |
| MDR pathogen (559/103) | 106,293 ± 128,447 (152-924,662) | 178,359 ± 198,247 (5,192-1,056,054) | <0.0001 |
| ICU stay (164/498) | 22,904 ± 39,715 (152-230,384) | 155,209 ± 146,719 (17,192-1,056,054) | <0.0001 |
| Gender (244/417) | 108,294 ± 140,070 (152-1,017,789) | 121,819 ± 147,405 (174-1,056,054) | 0.0990 |
| Age < 1 yr (439/166) | 101,476 ± 150,439 (152-1,056,054) | 159,035 ± 131,029 (2,680-825,512) | <0.0001 |
| Age ≥1 but <12 yr (582/23) | 115,311 ± 145,611 (152-1,056,054) | 95,262 ± 173,630 (5,712-624,182) | 0.2961 |
| Age ≥ 12 yr (189/416) | 150,610 ± 136,886 (2,680-825,512) | 101,753 ± 149,279 (152-1,056,054) | <0.0001 |
| BSI (452/210) | 113,115 ± 157,462 (152-1,056,054) | 116,471 ± 113,619 (2,956-614,990) | 0.2757 |
| Pneumonia (437/225) | 82,861 ± 112,403 (152-680,777) | 175,214 ± 171,641 (36,047-1,056,054) | <0.0001 |
| SSI (484/178) | 152,852 ± 147,997 (182-1,056,054) | 30,452 ± 89,415 (152-680,777) | <0.0001 |
| Otherc (613/48) | 113,580 ± 147,277 (152-1,056,054) | 158,559 ± 112,584 (181-624,181) | 0.1192 |
| Chemotherapy (650/12) | 116,471 ± 145,569 (152-1,056,054) | 45,821 ± 70,149 (4,309-215,382) | 0.0140 |
| Central venous line (517/145) | 113,580 ± 153,676 (152-1,056,054) | 116,628 ± 108,460 (4,308-614,990) | 0.3351 |
| Foley catheter (648/14) | 113,352 ± 145,921 (152-1,056,054) | 208,164 ± 71,808 (95,503-381,758) | 0.0033 |
| Neutropenia (652/10) | 115,842 ± 145,690 (152-1,056,054) | 113,722 ± 83,670 (15,985-305,952) | 0.9230 |
| TPN (584/78) | 112,947 ± 145,008 (152-1,056,054) | 149,661 ± 142,223 (17,192-825,512) | 0.0047 |
| Transplantation (658/4) | 114,420 ± 136,721 (152-924,662) | 661,870 ± 443,232 (236,583-1,056,054) | 0.0031 |
| Ventilator (441/221) | 82,861 ± 112,032 (152-680,777) | 177,585 ± 172,440 (36,046-1,056,054) | <0.0001 |
a
All costs are expressed in 2008 constant dollars.
b
Significance was determined at the 0.05 level.
c
Other includes UTIs.